Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Core Molecular Diagnostic Lab, |
RCV000722087 | SCV000852060 | pathogenic | Severe early-childhood-onset retinal dystrophy | 2018-11-13 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000722087 | SCV001135353 | pathogenic | Severe early-childhood-onset retinal dystrophy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868917 | SCV002235627 | pathogenic | not provided | 2020-11-22 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 16 of the ABCA4 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with retinal disease (PMID: 25474345, 32307445, Invitae). ClinVar contains an entry for this variant (Variation ID: 590903). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005027888 | SCV005659535 | likely pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2024-04-19 | criteria provided, single submitter | clinical testing |